Answer
Vinblastine sulfate combined with mitomycin has been associated with potentially fatal acute respiratory distress or failure, pulmonary infiltrates or oedema, acute breathlessness, severe bronchospasm and progressive breathlessness requiring chronic therapy, with reactions potentially serious in patients with pre-existing pulmonary dysfunction.
Sources for this answer
- Vinblastine Sulfate 1 mg/ml InjectionHospira UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 18Document updated
Sources checked